Quick, Sensitive Detection of Alzheimer's Disease Biomarkers using Multiplexing

In a poster presentation at the Neuroscience 2017 conference, Dr. Anthony Saporita, senior scientist at MilliporeSigma, explains how multiplex technology can be applied to detect biomarkers in Alzheimer’s disease. He further discusses the launch of the highly sensitive SMC kits for Aβ42 detection in human CSF and plasma.